Challenges Associated with the Integration of Endovascular Repair of Abdominal Aortic Aneurysms in a Community Hospital
Purpose: There has been considerable debate regarding the proper place for endovascular repair (ER) of abdominal aortic aneurysms (AAAs) versus traditional open repair (OR). Our study compared preoperative patient demographics and outcomes for elective, asymptomatic AAA repairs performed at our center over a 33-month period.
Methods: For this study, we selected 342 consecutive elective infrarenal AAA repairs performed between July 1, 2000, and March 31, 2003, at Riverside Methodist Hospital. The patients underwent either ER or OR, depending on patient and surgeon collaborative determinations. Ruptured and symptomatic AAAs were excluded from our study. Preoperative demographics, anesthesia, complications, and discharge status for the 2 groups were analyzed, and statistical analysis was done to determine statistically significant differences.
Results: The preoperative status of the ER and OR patient groups were essentially similar. There were only 3 significant differences between the 2 groups: alcohol use was higher for the OR group than for the ER group (12.0% versus 5.2%; P = .04), and the incidence of type II diabetes mellitus and peripheral vascular disease were lower for the OR group compared with the ER group (6.7% versus 13.4% [P = .04] and 18.3% versus 30.6% [P = .008], respectively). The OR group used more general anesthesia than the ER group (99% versus 86%; P < .001) and had more complications, including dysrhythmia (8.65% versus 1.59%; P = .005), ileus (13.94% versus 0.79%; P < .0001), infection (8.17% versus 0.0%; P = .0007), respiratory complications (12.50% versus 1.59%; P = .0003), and renal complications (5.29% versus 0.79%; P = .032). The ER group had a higher rate of wound hematoma (4.76% versus 0.48%; P = .007). ER patients also
Aquino RV, Jones MA, Zullo TG, Missig-Carroll N, Makaroun MS. 2001. Quality of life assessment in patients undergoing endovascular or conventional AAA repair. J Endovasc Ther 8:521-8.nBaum RA, Carpenter JP, Constantin C, et al. 2001. Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg 33:32-41.nBecker GJ, Kovacs M, Mathison MN, et al. 2001. Risk stratification and outcomes of transluminal endografting for abdominal aortic aneurysm: 7-year experience and long-term follow-up. J Vasc Interv Radiol 12:1033-46.nBush RL, Lumsden AB, Dodson TF, et al. 2001. Mid-term results after endovascular repair of the abdominal aortic aneurysm. J Vasc Surg 33:S70-6.nCarpenter JP, Neschis DG, Fairman RM, et al. 2001. Failure of endovascular abdominal aortic graft limbs. J Vasc Surg 33:296-303.nCollin J, Murie JA. 2001. Endovascular treatment of abdominal aortic aneurysm: a failed experiment. Br J Surg 88:1281-2.nDjokovic JL, Hedley-Whyte J. 1979. Prediction of outcome of surgery and anesthesia in patients over 80. JAMA 242:2301-6.nDorffner R, Thurnher S, Polterauer P, Kretschmer G, Lammer J. 1997. Treatment of abdominal aortic aneurysms with transfemoral placement of stent-grafts: complications and secondary intervention. Radiology 204:79-86.nDrott C, Arfvidsson B, Ortenwall P, Lundholm K. 1992. Age-standardized incidence of ruptured aortic aneurysm in a defined Swedish population between 1952 and 1988: mortality rate and operative results. Br J Surg 79:175-9.nErnst CB. 1993. Abdominal aortic aneurysms. N Engl J Med 328:1167-72.nFeigal DW. 2001. Problems with endovascular grafts for the treatment of abdominal aortic aneurysm (AAA). J Vasc Surg 33:1361-2.nHarris PL, Vallabhaneni SR, Desgranges P, Becquemin JP, van Marrewijk C, Laheij RJF, for the EUROSTAR collaborators. 2000. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg 32:739-49.nIngoldby CJH, Wujanto R, Mitchell JE. 1986. Impact of vascular surgery on community mortality from ruptured aortic aneurysms. Br J Surg 73:551-3.nJohnston KW. 1989. Multicenter prospective study of nonruptured abdominal aortic aneurysm, part II: variables predicting morbidity and mortality. J Vasc Surg 9:437-47.nLigush J Jr, Pearce J, Edwards MS, et al. 2002. Analysis of medical risk factors and outcomes in patients undergoing open versus endovascular abdominal aortic aneurysm repair. J Vasc Surg 36:492-9.nMay J, White GH, Yu W, et al. 1998. Concurrent comparison of endoluminal versus open repair in the treatment of abdominal aortic aneurysms: analysis of 303 patients by life table method. J Vasc Surg 27:213-21.nOhki T, Veith FJ, Shaw P, et al. 2001. Increasing incidence of midterm and long-term complications after endovascular graft repair of abdominal aortic aneurysms: a note of caution based on a 9-year experience. Ann Surg 234:323-34.nPilcher DB, Davis JH, Ashikaga T, et al. 1980. Treatment of abdominal aortic aneurysm in an entire state over 7 1/2 years. Am J Surg 139:487-94.nPolitz JK, Newman VS, Stewart MT. 2000. Late abdominal aortic aneurysm rupture after AneuRx repair: a report of three cases. J Vasc Surg 31:599-606.nRutledge R, Oller DW, Meyer AA, Johnson GJ. 1996. A statewide, population-based, time-series analysis of the outcome of ruptured abdominal aortic aneurysm. Ann Surg 223:492-505.nSalartash K, Sternbergh WC, York JW, Money SR. 2001. Comparison of open transabdominal AAA repair with endovascular AAA in reduction of postoperative stress response. Ann Vasc Surg 15:53-9.nSapirstein W, Chandeysson P, Wentz C. 2001. The Food and Drug Administration approval of endovascular grafts for abdominal aortic aneurysm: an 18-month retrospective. J Vasc Surg 34:180-3.nSullivan CA, Rohrer MJ, Cutler BS. 1990. Clinical management of symptomatic but unruptured abdominal aortic aneurysm. J Vasc Surg 11:799-803.nThomas PRS, Stewart RD. 1988. Abdominal aortic aneurysm. Br J Surg 75:733-6.nZarins CK, White RA, Moll FL, et al. 2001. The AneuRx stent graft: four-year results and worldwide experience 2000. J Vasc Surg 33:S135-45.nZarins CK, White RA, Schwarten D, et al. 1999. AneuRx stent graft versus open aneurysms: multicenter trial. J Vasc Surg 29:292-308.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).